Detalhe da pesquisa
1.
qRT-PCR analysis of CEACAM5, KLK6, SLC35D3, MUC2 and POSTN in colon cancer lymph nodes-An improved method for assessment of tumor stage and prognosis.
Int J Cancer
; 154(3): 573-584, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700602
2.
Prognostic Significance of GPR55 mRNA Expression in Colon Cancer.
Int J Mol Sci
; 23(9)2022 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-35562947
3.
The myeloid cell biomarker EMR1 is ectopically expressed in colon cancer.
Tumour Biol
; 43(1): 209-223, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34486997
4.
CEACAM5, KLK6, SLC35D3, POSTN, and MUC2 mRNA Analysis Improves Detection and Allows Characterization of Tumor Cells in Lymph Nodes of Patients Who Have Colon Cancer.
Dis Colon Rectum
; 64(11): 1354-1363, 2021 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192710
5.
Clinical Significance of Stem Cell Biomarkers EpCAM, LGR5 and LGR4 mRNA Levels in Lymph Nodes of Colon Cancer Patients.
Int J Mol Sci
; 23(1)2021 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008827
6.
Evaluating macrophage migration inhibitory factor 1 expression as a prognostic biomarker in colon cancer.
Tumour Biol
; 42(6): 1010428320924524, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32515296
7.
Utility of G protein-coupled receptor 35 expression for predicting outcome in colon cancer.
Tumour Biol
; 41(6): 1010428319858885, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31250711
8.
The Chemokine CXCL16 Is a New Biomarker for Lymph Node Analysis of Colon Cancer Outcome.
Int J Mol Sci
; 20(22)2019 Nov 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31752131
9.
Lymph node CXCL17 messenger RNA: A new prognostic biomarker for colon cancer.
Tumour Biol
; 40(9): 1010428318799251, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30198422
10.
Ectopic expression of the chemokine CXCL17 in colon cancer cells.
Br J Cancer
; 114(6): 697-703, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26889977
11.
Water soluble contrast enema examination of the integrity of the rectal anastomosis prior to loop ileostomy reversal may be superfluous.
Int J Colorectal Dis
; 30(3): 381-4, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25598042
12.
LGR6 is a prognostic biomarker for less differentiated tumors in lymph nodes of colon cancer patients.
Front Oncol
; 14: 1393075, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38715790
13.
Validity of the Swedish Rectal Cancer Registry for patients treated with major abdominal surgery between 1995 and 1997.
Acta Oncol
; 52(8): 1707-14, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23786178
14.
Detection of lymph node metastasis in colon cancer by ectopically expressed fibroblast markers FOXQ1 and THBS2.
Front Oncol
; 13: 1297324, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38156105
15.
Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer.
Int J Cancer
; 130(8): 1833-43, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21618511
16.
Morbidity related to defunctioning loop ileostomy in low anterior resection.
Int J Colorectal Dis
; 27(12): 1619-23, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22576906
17.
Ezrin expression in rectal cancer predicts time to development of local recurrence.
Int J Colorectal Dis
; 27(7): 893-9, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22234584
18.
Oncological outcome after incidental perforation in radical rectal cancer surgery.
Int J Colorectal Dis
; 25(6): 731-40, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20349075
19.
Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis.
PLoS One
; 15(2): e0229007, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32049988
20.
The impact of hospital volume on surgical outcome in patients with rectal cancer.
Dis Colon Rectum
; 52(9): 1542-9, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19690480